Genecept Assay

DEVICE3 trials

Sponsors

Genomind, LLC

Conditions

Generalized Anxiety DisorderMajor Depressive DisorderTreatment Resistant Depression

Unknown Phase

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

TerminatedNCT01426516

Genomind, LLCMajor Depressive Disorder

Start: 2011-09-30End: 2014-06-30Updated: 2021-09-13

An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression

WithdrawnNCT01438242

Genomind, LLCMajor Depressive Disorder

Start: 2015-01-31End: 2016-01-31Updated: 2015-03-23

An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay

CompletedNCT01507155

Genomind, LLCGeneralized Anxiety Disorder, Treatment Resistant Depression

Start: 2013-04-30End: 2014-05-31Updated: 2016-06-08

Related Papers

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders

The Primary Care Companion For CNS Disorders2015-04-1551 citations